Research & Development



“就說??這樣傾心相愛簡直是兒戲,是胡鬧。您必須打消她的這種念 “當然?  彼牧痴嗆熗耍 安還矣植荒  鍪裁矗 看蝸擄回來,我已經因為擔驚受怕給折磨壞了。唉,要是您能對他施加些影響就好 了!他需要有一個人稍稍控制他一下。一個人總幫不了所有人的忙啊??” “不過總得想想辦法吧,”康多爾說道,一面用眼楮瞅著我。“人可不 就是為了這個而活著的嗎。只是為了這個而活啊。”我感到這個警告一直打 入我的內心。然而,我經受住了他的這道目光,自從我明白了我就已經下定a片毛片免费视频在线看 我不知道我這念頭是怎麼來的。可是我想向什麼人或者什麼東西發泄一 下我的怒火,想找人毆斗、廝打,這種欲望在我心里是如此強烈,以致踫巧 有個碴兒,我就抓住不放。大家都不勝驚訝地瞅著我。日本av不卡在线观看 對嗎?”欧美视频 四十三

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo